☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Compass Therapeutics Reports the First Patient Dosing of CTX-471 + Keytruda (pembrolizumab) for the Treatment of Advanced Solid Tu...
December 2, 2022
PharmaShots Weekly Snapshots (November 28 – December 02, 2022)
December 2, 2022
Qilu Pharmaceutical Presents P-II Study Results of QL1706 for the Treatment of Non-Small Cell Lung Cancer at ESMO 2022
December 2, 2022
Rigel’s Rezlidhia (olutasidenib) Receives the US FDA’s Approval for the Treatment of Acute Myeloid Leukemia with a Susceptible IDH...
December 2, 2022
UroGen Presents P-III (OLYMPUS) Trial Results of Jelmyto (mitomycin) for the Treatment of Low-Grade Upper Tract Urothelial Cancer...
December 2, 2022
Anavex Presents P-IIb/III (ANAVEX 2-73-AD-004) Trial Results of ANAVEX 2–73 (blarcamesine) for Early Alzheimer’s Disease at CTAD 2...
December 2, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions